At the present time alcoholism is recognized as a metabolic disease ex
hibiting the clinical features of craving for alcohol, loss of control
over drinking, tolerance and physical dependence on alcohol, while bo
th epidemiological and experimental studies have demonstrated that gen
etic factors may be important in determining whether an individual has
a high or low vulnerability to develop alcoholism. Evidence also indi
cates that alcoholism is not characterized by a single gene single all
ele inheritance. Instead it seems that multiple genes and environmenta
l factors interact to increase or decrease an individual's vulnerabili
ty to become an alcoholic. Current research is aimed al investigating
whether certain behavioral, physiological and biochemical markers are
highly associated with the incidence of alcoholism. Among the biochemi
cal markers currently under investigation is the endogenous opioid sys
tem and its implication in mediating the reinforcing effects of ethano
l. It is the objective of this manuscript to review current research a
n: (a) the interactions of ethanol with the endogenous opioid system a
t the molecular level; (b) the existence of genetically determined dif
ferences in the response of the endogenous opioid system to ethanol be
tween subjects at high and low risk for excessive ethanol consumption,
as well as between lines of animals showing preference or aversion fo
r ethanol solutions; (c) the decrease of alcohol consumption following
pretreatment with opioid antagonists; and (d) the possible use of spe
cific opioid receptor antagonists together with behavioral therapy to
modify drinking behavior, to control craving and to prevent relapse.